Dental Mesenchymal Stem/Stromal Cells and Their Exosomes

Stem cells derived from human dental pulp tissue (DP-MSC) differ from the other mesenchymal stem cells prepared from bone marrow or adipose tissue due to their embryonic origin from the neural crest and are of special interest because of their neurotropic character. Furthermore, the therapeutic pote...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Stanko, Ursula Altanerova, Jana Jakubechova, Vanda Repiska, Cestmir Altaner
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2018/8973613
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552731998420992
author Peter Stanko
Ursula Altanerova
Jana Jakubechova
Vanda Repiska
Cestmir Altaner
author_facet Peter Stanko
Ursula Altanerova
Jana Jakubechova
Vanda Repiska
Cestmir Altaner
author_sort Peter Stanko
collection DOAJ
description Stem cells derived from human dental pulp tissue (DP-MSC) differ from the other mesenchymal stem cells prepared from bone marrow or adipose tissue due to their embryonic origin from the neural crest and are of special interest because of their neurotropic character. Furthermore, the therapeutic potential of DP-MSCs is realized through paracrine action of extracellularly released components, for which exosomes play an important role. In this review, we intend to explore the properties of these cells with an emphasis on exosomes. The therapeutic applicability of these cells and exosomes in dental practice, neurodegenerative diseases, and many other difficultly treatable diseases, like myocardial infarction, focal cerebral ischemia, acute lung or brain injury, acute respiratory distress syndrome, acute inflammation, and several others is concisely covered. The use of cellular exosomes as an important diagnostic marker and indicator of targeted cancer therapies is also discussed, while the importance of stem cells from human exfoliated deciduous teeth as a source of evolutionally young cells for future regenerative therapies is stressed. We conclude that exosomes derived from these cells are potent therapeutic tools for regenerative medicine in the near future as clinical administration of DP-MSC-conditioned medium and/or exosomes is safer and more practical than stem cells.
format Article
id doaj-art-a1ee6486f45d4f358fdb4bb7e0dd3d71
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-a1ee6486f45d4f358fdb4bb7e0dd3d712025-02-03T05:58:05ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/89736138973613Dental Mesenchymal Stem/Stromal Cells and Their ExosomesPeter Stanko0Ursula Altanerova1Jana Jakubechova2Vanda Repiska3Cestmir Altaner4Department of Stomatology and Maxillofacial Surgery, Faculty of Medicine, Comenius University in Bratislava, Bratislava, SlovakiaDepartment of Stem Cell Preparation, St. Elisabeth Cancer Institute, Bratislava, SlovakiaDepartment of Stem Cell Preparation, St. Elisabeth Cancer Institute, Bratislava, SlovakiaInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Bratislava, SlovakiaDepartment of Stem Cell Preparation, St. Elisabeth Cancer Institute, Bratislava, SlovakiaStem cells derived from human dental pulp tissue (DP-MSC) differ from the other mesenchymal stem cells prepared from bone marrow or adipose tissue due to their embryonic origin from the neural crest and are of special interest because of their neurotropic character. Furthermore, the therapeutic potential of DP-MSCs is realized through paracrine action of extracellularly released components, for which exosomes play an important role. In this review, we intend to explore the properties of these cells with an emphasis on exosomes. The therapeutic applicability of these cells and exosomes in dental practice, neurodegenerative diseases, and many other difficultly treatable diseases, like myocardial infarction, focal cerebral ischemia, acute lung or brain injury, acute respiratory distress syndrome, acute inflammation, and several others is concisely covered. The use of cellular exosomes as an important diagnostic marker and indicator of targeted cancer therapies is also discussed, while the importance of stem cells from human exfoliated deciduous teeth as a source of evolutionally young cells for future regenerative therapies is stressed. We conclude that exosomes derived from these cells are potent therapeutic tools for regenerative medicine in the near future as clinical administration of DP-MSC-conditioned medium and/or exosomes is safer and more practical than stem cells.http://dx.doi.org/10.1155/2018/8973613
spellingShingle Peter Stanko
Ursula Altanerova
Jana Jakubechova
Vanda Repiska
Cestmir Altaner
Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
Stem Cells International
title Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
title_full Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
title_fullStr Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
title_full_unstemmed Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
title_short Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
title_sort dental mesenchymal stem stromal cells and their exosomes
url http://dx.doi.org/10.1155/2018/8973613
work_keys_str_mv AT peterstanko dentalmesenchymalstemstromalcellsandtheirexosomes
AT ursulaaltanerova dentalmesenchymalstemstromalcellsandtheirexosomes
AT janajakubechova dentalmesenchymalstemstromalcellsandtheirexosomes
AT vandarepiska dentalmesenchymalstemstromalcellsandtheirexosomes
AT cestmiraltaner dentalmesenchymalstemstromalcellsandtheirexosomes